News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Three Months Of 2014


5/15/2014 6:18:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HORSHOLM, Denmark, May 14, 2014 /PRNewswire/ --

Highlights:

-- The U.S. Food and Drug Administration (FDA) has accepted for standard review the company's New Drug Application (NDA) for Envarsus(R) for the prevention of organ rejection in adult kidney transplant patients.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES